Confidentiality of Certain Medical Records Under the MISSION Act, 407 [2018-28285]
Download as PDF
407
Rules and Regulations
Federal Register
Vol. 84, No. 18
Monday, January 28, 2019
This section of the FEDERAL REGISTER
contains regulatory documents having general
applicability and legal effect, most of which
are keyed to and codified in the Code of
Federal Regulations, which is published under
50 titles pursuant to 44 U.S.C. 1510.
The Code of Federal Regulations is sold by
the Superintendent of Documents.
DEPARTMENT OF VETERANS
AFFAIRS
38 CFR Part 17
Confidentiality of Certain Medical
Records Under the MISSION Act
Department of Veterans Affairs.
Notification of change to agency
practice.
AGENCY:
ACTION:
This Department of Veterans
Affairs (VA) document provides an
update to VA’s requirements for
obtaining a signed release of
information for third party billing
practices from VA beneficiaries with a
sensitive diagnosis under the United
States Code to align with the
amendments made by the VA MISSION
Act of 2018.
DATES: Effective January 28, 2019.
FOR FURTHER INFORMATION CONTACT:
Jennifer Adams, Office of Community
Care (10D), Veterans Health
Administration, Department of Veterans
Affairs, 810 Vermont Avenue NW,
Washington, DC 20420,
Jennifer.Adams26@va.gov, (615) 355–
1539. This is not a toll free number.
SUPPLEMENTARY INFORMATION: On June 6,
2018, section 132 of Public Law 115–
182, the John S. McCain III, Daniel K.
Akaka, and Samuel R. Johnson VA
Maintaining Internal Systems and
Strengthening Integrated Outside
Networks Act of 2018 (MISSION Act),
amended 38 U.S.C. 7332,
Confidentiality of certain medical
records, which protects certain sensitive
diagnoses (i.e., drug abuse, alcoholism
or alcohol abuse, infection with the
human immunodeficiency virus, or
sickle cell anemia) from being disclosed
unless expressly authorized by the
patient. The VA Mission Act of 2018
amended section 7332 by providing a
new exception to the requriment that a
patient must expressely authorize VA to
disclose medical records containing a
sensitive diagnosis. The exception
removed VA’s requirement when VA is
amozie on DSK3GDR082PROD with RULES
SUMMARY:
VerDate Sep<11>2014
16:01 Jan 25, 2019
Jkt 247001
billing a third-party for medical care
cost recovery.
In addition to this document, VA will
announce these changes on Veteranfacing websites to reach as many VA
beneficiaires as possible. VA will also
conduct a briefing with Veteran Service
Organizations to ensure they are
informed of the changes. For any VA
beneficiary who has previously signed a
release of information declining to allow
VA to bill encounters containing a
sensitive diagnosis, VA will provide a
one-time notification prior to submitting
claims with a sensitive diagnosis to a
third-party health insurer. The written
notification will include a summary of
the new law, how the change affects the
patient, and a description of the types
of services affected by the change.
After all of the aforementioned
notifications are complete, VA will
begin submitting claims to health
insurance companies for encounters
with dates of service on or after the
publication date of this document in the
Federal Register that contain a sensitive
diagnosis without a signed release of
information. While VA’s billing
authorities allow for a window of up to
6 years to bill a health insurance
company for services provided, VA will
not pursue any back billing for these
services unless a signed Request For and
Authorization to Release Medical
Records or Health Information (VHA–
10–5345) form for such release has been
received from the patient. All required
payer policies still apply to any services
submitted for reimbursement.
Signing Authority
The Secretary of Veterans Affairs, or
designee, approved this document and
authorized the undersigned to sign and
submit the document to the Office of the
Federal Register for publication
electronically as an official document of
the Department of Veterans Affairs.
Robert L. Wilkie, Secretary, Department
of Veterans Affairs, approved this
document on December 21, 2018, for
publication.
Dated: December 21, 2018.
Luvenia Potts,
Program Specialist, Office of Regulation
Policy & Management, Office of the Secretary,
Department of Veterans Affairs.
[FR Doc. 2018–28285 Filed 1–25–19; 8:45 am]
BILLING CODE 8320–01–P
PO 00000
Frm 00001
Fmt 4700
Sfmt 4700
DEPARTMENT OF COMMERCE
National Oceanic and Atmospheric
Administration
50 CFR Part 622
[Docket No. 101206604–1758–02]
RIN 0648–XG732
Coastal Migratory Pelagic Resources
of the Gulf of Mexico and Atlantic
Region; Commercial Trip Limit
Reduction for Spanish Mackerel in the
Atlantic Southern Zone
National Marine Fisheries
Service (NMFS), National Oceanic and
Atmospheric Administration (NOAA),
Commerce.
ACTION: Temporary rule; trip limit
reduction.
AGENCY:
NMFS reduces the
commercial trip limit of Atlantic
migratory group Spanish mackerel in or
from the exclusive economic zone (EEZ)
in the southern zone to 500 lb (227 kg)
per day. This trip limit reduction is
necessary to maximize the
socioeconomic benefits of the
commercial quota for the southern zone.
DATES: This rule is effective from 6 a.m.,
local time, January 27, 2019, until 12:01
a.m., local time, March 1, 2019.
FOR FURTHER INFORMATION CONTACT:
Mary Vara, NMFS Southeast Regional
Office, telephone: 727–824–5305, or
email: mary.vara@noaa.gov.
SUPPLEMENTARY INFORMATION: The
fishery for coastal migratory pelagic fish
includes king mackerel, Spanish
mackerel, and cobia, and is managed
under the Fishery Management Plan for
the Coastal Migratory Pelagic Resources
of the Gulf of Mexico and South
Atlantic (FMP). The FMP was prepared
by the Gulf of Mexico and South
Atlantic Fishery Management Councils
and is implemented under the authority
of the Magnuson-Stevens Fishery
Conservation and Management Act
(Magnuson-Stevens Act) by regulations
at 50 CFR part 622. All weights in this
temporary rule apply as either round or
gutted weight.
Framework Amendment 1 to the FMP
(79 FR 69058; November 20, 2014)
implemented a commercial annual
catch limit (equal to the commercial
quota) of 3.33 million lb (1.51 million
kg) for the Atlantic migratory group of
SUMMARY:
E:\FR\FM\28JAR1.SGM
28JAR1
Agencies
[Federal Register Volume 84, Number 18 (Monday, January 28, 2019)]
[Rules and Regulations]
[Page 407]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-28285]
========================================================================
Rules and Regulations
Federal Register
________________________________________________________________________
This section of the FEDERAL REGISTER contains regulatory documents
having general applicability and legal effect, most of which are keyed
to and codified in the Code of Federal Regulations, which is published
under 50 titles pursuant to 44 U.S.C. 1510.
The Code of Federal Regulations is sold by the Superintendent of Documents.
========================================================================
Federal Register / Vol. 84, No. 18 / Monday, January 28, 2019 / Rules
and Regulations
[[Page 407]]
DEPARTMENT OF VETERANS AFFAIRS
38 CFR Part 17
Confidentiality of Certain Medical Records Under the MISSION Act
AGENCY: Department of Veterans Affairs.
ACTION: Notification of change to agency practice.
-----------------------------------------------------------------------
SUMMARY: This Department of Veterans Affairs (VA) document provides an
update to VA's requirements for obtaining a signed release of
information for third party billing practices from VA beneficiaries
with a sensitive diagnosis under the United States Code to align with
the amendments made by the VA MISSION Act of 2018.
DATES: Effective January 28, 2019.
FOR FURTHER INFORMATION CONTACT: Jennifer Adams, Office of Community
Care (10D), Veterans Health Administration, Department of Veterans
Affairs, 810 Vermont Avenue NW, Washington, DC 20420,
Jennifer.Adams26@va.gov, (615) 355-1539. This is not a toll free
number.
SUPPLEMENTARY INFORMATION: On June 6, 2018, section 132 of Public Law
115-182, the John S. McCain III, Daniel K. Akaka, and Samuel R. Johnson
VA Maintaining Internal Systems and Strengthening Integrated Outside
Networks Act of 2018 (MISSION Act), amended 38 U.S.C. 7332,
Confidentiality of certain medical records, which protects certain
sensitive diagnoses (i.e., drug abuse, alcoholism or alcohol abuse,
infection with the human immunodeficiency virus, or sickle cell anemia)
from being disclosed unless expressly authorized by the patient. The VA
Mission Act of 2018 amended section 7332 by providing a new exception
to the requriment that a patient must expressely authorize VA to
disclose medical records containing a sensitive diagnosis. The
exception removed VA's requirement when VA is billing a third-party for
medical care cost recovery.
In addition to this document, VA will announce these changes on
Veteran-facing websites to reach as many VA beneficiaires as possible.
VA will also conduct a briefing with Veteran Service Organizations to
ensure they are informed of the changes. For any VA beneficiary who has
previously signed a release of information declining to allow VA to
bill encounters containing a sensitive diagnosis, VA will provide a
one-time notification prior to submitting claims with a sensitive
diagnosis to a third-party health insurer. The written notification
will include a summary of the new law, how the change affects the
patient, and a description of the types of services affected by the
change.
After all of the aforementioned notifications are complete, VA will
begin submitting claims to health insurance companies for encounters
with dates of service on or after the publication date of this document
in the Federal Register that contain a sensitive diagnosis without a
signed release of information. While VA's billing authorities allow for
a window of up to 6 years to bill a health insurance company for
services provided, VA will not pursue any back billing for these
services unless a signed Request For and Authorization to Release
Medical Records or Health Information (VHA-10-5345) form for such
release has been received from the patient. All required payer policies
still apply to any services submitted for reimbursement.
Signing Authority
The Secretary of Veterans Affairs, or designee, approved this
document and authorized the undersigned to sign and submit the document
to the Office of the Federal Register for publication electronically as
an official document of the Department of Veterans Affairs. Robert L.
Wilkie, Secretary, Department of Veterans Affairs, approved this
document on December 21, 2018, for publication.
Dated: December 21, 2018.
Luvenia Potts,
Program Specialist, Office of Regulation Policy & Management, Office of
the Secretary, Department of Veterans Affairs.
[FR Doc. 2018-28285 Filed 1-25-19; 8:45 am]
BILLING CODE 8320-01-P